Liberal RBC Transfusion Strategy Suggested for Acute Myocardial Infarction

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 25, 2025.

via HealthDay

MONDAY, Aug. 25, 2025 -- A liberal red blood cell (RBC) transfusion strategy is suggested for hospitalized patients with acute myocardial infarction (AMI) when the hemoglobin concentration is less than 10 g/dL, according to a clinical practice guideline issued by the Association for the Advancement of Blood & Biotherapies and published online Aug. 19 in the Annals of Internal Medicine.

Monica B. Pagano, M.D., from the University of Washington in Seattle, and colleagues developed recommendations for RBC transfusion in patients with AMI using evidence from randomized controlled trials of patients presenting with AMI and assigned to restrictive or liberal transfusion strategies based on hemoglobin concentrations or hematocrit levels before receipt of a transfusion.

The international panel suggested a liberal RBC transfusion strategy when the hemoglobin concentration is <10 g/dL for hospitalized patients with AMI (conditional recommendation, low-certainty evidence). In patients with AMI, a restrictive strategy of 7 to 8 g/dL may result in increased mortality. The recommendation toward a liberal strategy was based on the great importance of mortality for patients. Mitigation strategies to reduce potential adverse events associated with a liberal transfusion strategy should be adopted, the panel recommends. Transfusion decisions should incorporate the clinical context rather than just the hemoglobin concentration.

"Given the potential complications of transfusion and the scarcity of the blood supply, more definitive data are needed," write the authors of an accompanying editorial. "These guidelines mark only the beginning, not the culmination, of a worthwhile scientific inquiry. Meanwhile, clinicians should apply these guidelines with sound clinical judgment to tailor transfusion therapy in shared decision-making that incorporates individual patients’ values and preferences."

Several authors disclosed ties to relevant organizations.

Abstract/Full Text

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-08-26 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords